The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of AstraZeneca's 2013 sales performance.
Even though AstraZeneca (AZ) saw a 50% growth in the third quarter of this year with revenues of $9.86bn, it has announced that it has signed for-profit agreements for ... He said that while a normal profit margin in the drug industry might be around 20%,
Valneva announced last month that VLA2001 met both its primary endpoints in a phase 3 trial, delivering higher levels of neutralising antibodies than seen with the AstraZeneca vaccine and a better
This is not the first time a major pharma company has had to refile a premerger notice; Sanofi did it when acquiring Translate Bio, and AstraZeneca refiled the notification during an
High-level results from the phase 3 TOPAZ-1 trial showed that AstraZeneca (AZ)’s PD-L1-blocking monoclonal antibody Imfinzi (durvalumab) plus chemotherapy demonstrated a clinically meaningful survival benefit over ... The trial was unblinded early due
with the AstraZeneca vaccine. ... In addition to a strong immune response, VLA2001 also offers a tolerability profile that is statistically significant better than AstraZeneca, with fewer adverse reactions reported especially in the older population.
[ Previous 5 results ] 9 10 11 12 13 14 15 16 17 18 [ Next 5 results ]
Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...